Success Metrics

Active Trials
6(86%)

Phase Distribution

Ph phase_2
1
14%
Ph not_applicable
6
86%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

7

all time

Status Distribution
Active(6)
Other(1)

Detailed Status

Recruiting5
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
6
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (14.3%)
N/A6 (85.7%)

Trials by Status

active_not_recruiting114%
unknown114%
recruiting571%

Recent Activity

6 active trials
Showing 5 of 7
recruitingnot_applicable

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)

NCT04610372
active_not_recruitingnot_applicable

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

NCT02960087
recruitingphase_2

Intra-lesional Tumor Boost for Bulky Cervical Cancer

NCT07435376
recruitingnot_applicable

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

NCT05053555
recruitingnot_applicable

Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era

NCT06508567
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04610372Not Applicable

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)

Recruiting
NCT02960087Not Applicable

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

Active Not Recruiting
NCT07435376Phase 2

Intra-lesional Tumor Boost for Bulky Cervical Cancer

Recruiting
NCT05053555Not Applicable

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

Recruiting
NCT06508567Not Applicable

Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era

Recruiting
NCT04231006Not Applicable

Salvage HDR for Locally Recurrent Prostate Cancer

Recruiting
NCT04870567Not Applicable

HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer

Unknown

All 7 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
7